ACR/EULAR 2022 GPA Classification Criteria
2022 ACR/EULAR classification criteria for granulomatosis with polyangiitis (GPA): 10 weighted items (−5 to 17); a score of 5 or more classifies GPA. Apply only when small- or medium-vessel vasculitis has been diagnosed and mimics of vasculitis have been excluded.
Score interpretation
Score < 5: does not meet the 2022 GPA classification criteria
→ Consider MPA (MPO-ANCA), eosinophilic GPA (eGPA/Churg-Strauss), or other vasculitis
Score ≥ 5: meets the 2022 ACR/EULAR classification criteria for GPA
→ Urgent rheumatology/nephrology referral; ANCA titres; renal function; chest CT; consider rituximab or cyclophosphamide + high-dose steroids
Interpretation bands for the ANCA Vasculitis. Apply clinical judgement and local guidance.
References
- Robson JC, et al. 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology Classification Criteria for Granulomatosis with Polyangiitis. Arthritis Rheumatol. 2022;74(3):393-399.
Related
Curated clinical cross-links plus same-class fallbacks.
- Rituximab (Nephrology) · ANCA Vasculitis / Nephrotic Syndrome
- Cyclophosphamide (Nephrology) · ANCA Vasculitis / Lupus Nephritis
- Avacopan · C5a Receptor Inhibitor (ANCA Vasculitis)
- Avacopan (C5a Receptor Inhibitor — ANCA Vasculitis) · Complement C5a Receptor Antagonist (Oral Biologic)
- Colchicine · Anti-inflammatory — Neutrophilic Dermatoses / Vasculitis
- Lissamine Green 1% Eye Drops · Vital Dye — Ocular Surface Staining (Dry Eye Diagnosis)
- Cutaneous Lupus Erythematosus · BAD; EULAR
- Osteoporosis / Fragility Fracture · NOGG 2021; NICE NG147; NG224
- Arteritic AION (Giant Cell Arteritis) · RCOphth; BSR
- Osteoarthritis Hip / Knee Management · NICE NG226 (2022)
- Lupus Nephritis · EULAR/ERA-EDTA 2019; KDIGO 2024
- Rheumatoid Arthritis Management · NICE CG79 2018 / EULAR 2022
Decision support only — verify against a current formulary, NICE, or your local guideline before clinical use.